Christopher Berger

10PUBLICATIONS
35CO-AUTHORS
Epidemiological methodsPreventative health careDisease surveillanceDigital electronic devicesDigital processor architectures
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 25, 2024
Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda.

Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann

|Aug 16, 2024
Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda.

Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann

|Feb 20, 2024
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.

Fred C Semitala, Jillian L Kadota, Allan Musinguzi

|Jun 30, 2023
Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda.

Noah Kiwanuka, Alex Kityamuwesi, Rebecca Crowder

|May 30, 2023
Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.

Anna Leddy, Joseph Ggita, Christopher A Berger

|Dec 16, 2021
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.

Fred C Semitala, Jillian L Kadota, Allan Musinguzi

Pageof 2

Frequent Collaborators

8 joint publications

Achilles Katamba

7 joint publications

Adithya Cattamanchi

5 joint publications

David W Dowdy

4 joint publications

Jillian L Kadota